Maravai LifeSciences Reports Second Quarter 2025 Financial Results
MRVAnnounced organizational restructuring and operating cost reduction initiatives targeting more than $50 million in annualized cost savings
August 11, 2025Earnings
Read more →Announced organizational restructuring and operating cost reduction initiatives targeting more than $50 million in annualized cost savings